Parker Waichman LLP

Serious Side Effects Associated with Newer Type 2 Diabetes Medication

The newer class of type 2 diabetes drugs—sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors)—is under scrutiny as new information about SGLT2 inhibitor side effects emerges. The SGLT2 class includes Invokana (canagliflozin), Farxiga (dapagliflozin) and Jardiance (empagliflozin), and Glyxambi, an empagliflozin-linagliptin combination. SGLT2 inhibitors help control blood sugar in patients with type 2 diabetes by getting the kidneys […]

The newer class of type 2 diabetes drugs—sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors)—is under scrutiny as new information about SGLT2 inhibitor side effects emerges.

The SGLT2 class includes Invokana (canagliflozin), Farxiga (dapagliflozin) and Jardiance (empagliflozin), and Glyxambi, an empagliflozin-linagliptin combination.

SGLT2 inhibitors help control blood sugar in patients with type 2 diabetes by getting the kidneys to extract sugar from the blood and eliminate it through urination. The Food and Drug Administration (FDA) has approved SGLT2 inhibitors for the treatment of type 2 diabetes. SGLT2 inhibitors have not been formally evaluated as a treatment for type 1 diabetes.

In May 2015, the Food and Drug Administration (FDA) directed the manufacturers of Invokana and other SGLT2 inhibitors to amend the warning labels to list the risk of ketoacidosis.

Diabetic ketoacidosis is a life-threatening condition that develops when the body is unable to get the sugar (glucose) needed for energy because the body does not have enough insulin, the hormone that controls blood sugar. When the cells cannot get sugar for energy, the body begins to break down fat and muscle for energy and ketones (fatty acids) are produced. Ketones enter the bloodstream, causing the chemical imbalance diabetic ketoacidosis, WebMD explains.

Ketoacidosis is a known risk for diabetes patients, though it is typically a complication of type 1 diabetes rather than type 2. Ketoacidosis usually occurs in the presence of higher than normal blood sugar levels.

The FDA followed the May 2015 warning with a December 2015 order for a label change for Invokana and other SGLT2 inhibitors. The new label will describe the risk of ketoacidosis and give prescribing and monitoring recommendations. Manufacturers will also be required to conduct a post-marketing study, analyzing side effect reports and following up with patients over the course of five years.

The label change were prompted by the FDA’s review adverse event reports: there were 73 ketoacidosis reports from March 2013 to May 2015 in patients being treated with SGLT2 inhibitors. Because this reporting is voluntary, the FDA notes that there may have been ketoacidosis cases that went unreported during that time period

The FDA now recommends that patients stop taking an SGLT2 inhibitor immediately and seek medical attention if they experience any symptoms of ketoacidosis. Symptoms can include “nausea, vomiting, abdominal pain, tiredness, and trouble breathing,” the FDA says.

The FDA’s December 2015 safety announcement also noted other serious side effects experienced by SGLT2 inhibitor users. Between March 2013 and October 2014, the agency received 19 reports of urinary tract infections that developed into either life-threatening blood infections or kidney infections. These cases all required hospitalizations and some of the patients developed kidney failure requiring dialysis or intensive care treatment.

Other SGLT2 inhibitor side effects include dehydration, yeast infections and increased blood cholesterol. SGLT2 inhibitors can also lead to low blood sugar when used in combination with other diabetes medications.

 

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Alex explored the position of each defendant to assist in making an informed decision on my part. I appreciate his efforts to explore options and resolve the case. Thank you for your diligence.
asha bell
a year ago
5 Star Reviews 150
You guys are the best lawyer institutions i have ever know thank you for helping me so much with my case ❤️
estarlin torres
9 months ago
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness I am so thankful for Parker Waichman’s team. Tina morace was so professional and knowledgeable.
Carol Willis
2 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038